Showing 1 - 1 of 1 trials – Showing only trials currently accepting patients
-
SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes
Stanford is currently accepting patients for this trial.
Latest information on COVID-19